Insider track record Other Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Julie Brown. Officer active across 1 company, notably GSK plc. In total, 60 filings have been logged. History available since 23 June 2023. The latest transaction was filed on 11 August 2026 (Purchase). Regulator: RNS (LSE). All data is openly available.
Companies and markets linked to Julie Brown Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations 60 total
● Chief Financial Officer · Executives · 11 Aug 2026 · GSK plc 14 shares @ £19.3493 London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9721245-1 ● Chief Financial Officer · Executives · 11 Aug 2026 · GSK plc 14 shares @ £19.3493 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63FCA-NSM:802aebe3-75c1-4ba5-8333-3c8ccb6de1b0-1 ● Chief Financial Officer · Executives · 10 Jul 2026 · GSK plc 1,636 shares @ £19.595 0.0042% mcap 0.2% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9668630-16 ● Chief Financial Officer · Executives · 9 Jul 2026 · GSK plc 12 shares @ £19.6292 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9666294-1 ● Chief Financial Officer · Executives · 9 Jul 2026 · GSK plc 12 shares @ £19.6292 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:06e0a094-373b-4460-b97c-91525b0dd5d9-1 ● Chief Financial Officer · Executives · 9 Jun 2026 · GSK plc 14 shares @ £18.8393 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9614374-1 ● Chief Financial Officer · Executives · 9 Jun 2026 · GSK plc 14 shares @ £18.8393 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:03338973-0058-4811-9fe5-7b22157346a2-1 ● Chief Financial Officer · Executives · 12 May 2026 · GSK plc 14 shares @ £18.778 0.0000% mcap 100.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:9569357-1 ● Chief Financial Officer · Executives · 12 May 2026 · GSK plc 14 shares @ £18.6557 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:eaad27f1-a91f-4bc4-815a-149202956de0-1 ● Chief Financial Officer · Executives · 27 Apr 2026 · GSK plc 243,880 shares 0
N/AISIN ISIN GB00BN7SWP63RNS:4a0e6e48-fd78-4de5-a74a-ff4879a0f254 ● Chief Financial Officer · Executives · 14 Apr 2026 · GSK plc 1,553 shares @ £21.67 0.0001% mcap 0.2% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-1 ● Chief Financial Officer · Executives · 13 Apr 2026 · GSK plc 10 shares @ £21.709 0.0000% mcap 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:bae2311e-28b0-4835-a894-0209eedccba9-1 ● Chief Financial Officer · Executives · 10 Mar 2026 · GSK plc 12 shares @ £20.7167 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:08be650c-10c4-4fa5-9cae-5b89efa04716-1 ● Chief Financial Officer · Executives · 12 Feb 2026 · GSK plc 196,548 shares @ £21.50 25.6% of flow N/AISIN ISIN GB00BN7SWP63RNS:586c5c74-54b9-425a-a37c-ba21836ecce7-1 ● Chief Financial Officer · Executives · 12 Feb 2026 · GSK plc 55,178 shares @ £21.50 7.2% of flow N/AISIN ISIN GB00BN7SWP63RNS:6207777f-2477-470b-868f-21f92714189a-1 ● Chief Financial Officer · Executives · 10 Feb 2026 · GSK plc 12 shares @ £21.7917 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:f7024c14-f781-4e48-a904-495085bc7ca2-1 ● Chief Financial Officer · Executives · 9 Jan 2026 · GSK plc 1,106 shares @ £18.91 0.1% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-25 ● Chief Financial Officer · Executives · 12 Jan 2026 · GSK plc 14 shares @ £18.9321 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-42 ● Chief Financial Officer · Executives · 9 Dec 2025 · GSK plc 12 shares @ £18.0783 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:58b71e9c-e0b4-4fdd-8b21-5f1119d38ddd-1 ● Chief Financial Officer · Executives · 11 Nov 2025 · GSK plc 14 shares @ £18.1421 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:802a4789-60c0-4a7f-a34b-b750f1d9f048-1 ● Chief Financial Officer · Executives · 10 Oct 2025 · GSK plc 1,264 shares @ £16.40 0.2% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:5862277-1 ● Chief Financial Officer · Executives · 9 Oct 2025 · GSK plc 16 shares @ £16.4081 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:5857218-1 ● Chief Financial Officer · Executives · 9 Sept 2025 · GSK plc 16 shares @ £14.8575 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:5815851-1 ● Chief Financial Officer · Executives · 11 Aug 2025 · GSK plc 18 shares @ £14.0844 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:5777526-1 ● Chief Financial Officer · Executives · 9 Jul 2025 · GSK plc 18 shares @ £14.2072 0.0% of flow London Stock Exchange (XLON)ISIN ISIN GB00BN7SWP63RNS:5737340-1 25 of 60 declarations
Load more (35 remaining) About Julie Brown Julie Brown is a declarant linked to GSK plc, where she is Chief Financial Officer. She has 56 filings in total, and across the 56 sampled filings, purchases total 744707 EUR with no sales reported, between 2023-06-23 and 2026-07-14.